© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
February 09, 2021
Insulin resistance and type 2 diabetes were major contributors to premature coronary heart disease, according to the study results.
February 08, 2021
The American Heart Association (AHA) is urging those with heart conditions and those who are at risk for cardiovascular disease to receive the COVID-19 vaccine.
February 03, 2021
Pharmacists can help patients through education, therapy, and lifestyle modifications.
January 28, 2021
The latest Heart Disease and Stroke Statistical Update highlighted pandemic-related trends that may impact cardiovascular disease mortality for years.
A recent study examined patient characteristics and factors affecting COVID-19 mortality in individuals with diabetes.
January 22, 2021
Investigators compared outcomes among patients with COVID-19 and hypertension through modifying blood pressure medication use.
January 20, 2021
The FDA has approved vericiguat (Verquvo; Merck) for use in patients with chronic heart failure (HF) and ejection fraction less than 45%.
January 19, 2021
High blood pressure appears to accelerate a decline in cognitive performance in middle-aged and older adults, according to new research.
January 12, 2021
Results of a recent study showed that both high and low density lipoprotein cholesterol were linked to an increase risk of all-cause mortality in the general population.
January 08, 2021
The agency granted priority review to dapagliflozin (Farxiga; AstraZeneca) for the treatment of new or worsening chronic kidney disease in adults with and without type 2 diabetes.